Log In
Print
BCIQ
Print
Print this Print this
 

SR-3306

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionC-jun N-terminal kinase (JNK) inhibitor
Molecular Target c-jun N-terminal kinase (JNK)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner

The Scripps Research Institute


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today